Biomarin Pharmaceutical (BMRN) Convertible Debt (2009 - 2025)
Biomarin Pharmaceutical (BMRN) reported Convertible Debt of $597.18 million for Q4 2025, up 0.3% from $595.14 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Convertible Debt (2009 - 2025) Analysis & Trends
Dating back to Q4 2009, Biomarin Pharmaceutical's Convertible Debt record includes 64 quarters.
- Convertible Debt has a five-year compound annual growth rate of -11.1% (FY2020 to FY2025).
- By year, Convertible Debt came in at $595.14 million in FY2024 (-45.2%), $1.09 billion in FY2023 (+0.4%), $1.08 billion in FY2022 (+0.4%) and $1.08 billion in FY2021 (+0.4%).
- The Q4 2025 figure ranks as the highest quarterly Convertible Debt since Q2 2024.
- Year over year, Convertible Debt gained in four of the last eight quarters, with an average decline of 22.4%.
- The high point for year-over-year Convertible Debt in five years was Q1 2021 (growth of 26.2%); the low point was Q2 2025 (a decline of 45.3%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $596.66 million (Q3 2025), $596.16 million (Q2 2025) and $595.65 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 597.18 Mn |
| Sep 30, 2025 | 596.66 Mn |
| Jun 30, 2025 | 596.16 Mn |
| Mar 31, 2025 | 595.65 Mn |
| Dec 31, 2024 | 595.14 Mn |
| Sep 30, 2024 | 594.63 Mn |
| Jun 30, 2024 | 1.09 Bn |
| Mar 31, 2024 | 1.09 Bn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.09 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 1.08 Bn |
| Dec 31, 2022 | 1.08 Bn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 1.08 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | 1.08 Bn |
| Sep 30, 2021 | 1.08 Bn |
| Jun 30, 2021 | 1.08 Bn |
| Mar 31, 2021 | 1.08 Bn |
API Access
Biomarin Pharmaceutical Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();